Bluebird bio Inc. (BLUE) said on Monday its partner Bristol Myers Squibb Co.
It’s a very rewarding trading day for investors in bluebird bio Inc (NASDAQ:BLUE) with shares up nearly 25%, making the stock Wall Street’s …
Bluebird Bio Inc (NASDAQ:BLUE) just attracted another bull to its biotech table, with Canaccord analyst John Newman believing the company’s collaboration with Celgene …
In a research report published May 6, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on bluebird bio Inc (NASDAQ:BLUE) with a price …
